Dow Jones

39 512,84

0,32%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
BioPlus Acquisition Corporation (BIOSU)
BioPlus Acquisition Corporation (BIOSU) Actualités

BIOSU

BioPlus Acquisition (BIOSU)

BioPlus Acquisition Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:BIOSU

Date	Heure	Source	Titre	Symbole	Société
16/10/2023	22h15	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	13h39	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	13h32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIOSU	BioPlus Acquisition Corporation
04/10/2023	13h30	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/09/2023	22h00	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/08/2023	22h11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/06/2023	12h09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/06/2023	12h06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/05/2023	22h29	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
15/05/2023	12h38	Edgar (US Regulatory)	Securities Registration: Business Combination (s-4)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
12/05/2023	22h17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
27/04/2023	22h35	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
14/02/2023	21h39	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
02/02/2023	16h10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
11/03/2022	22h05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOSU	BioPlus Acquisition Corporation
06/12/2021	14h00	GlobeNewswire Inc.	BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering	NASDAQ:BIOSU	BioPlus Acquisition Corporation